The ROE (Return on Equity) of 4D Molecular Therapeutics Inc (FDMT) is -31.51%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
Date | Value |
---|---|
2024-12-31 | -31.51% |
2023-12-31 | -32.76% |
2022-12-31 | -46.47% |
2021-12-31 | -22.35% |
2020-12-31 | -22.11% |
2019-12-31 | -164.37% |
2018-12-31 | -12.67% |
2017-12-31 | 1020.00% |